Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
---|
07/10/1996 | EP0720855A2 Composition for the treatment of hypertension comprising non halide salts of potassium |
07/10/1996 | EP0457888B1 Octapeptide analogs of somatostatin having threonine at the sixth position |
07/03/1996 | EP0719776A1 8-Oxo-5,8-dihydro-6H-dibenzo(a,g) quinolizine-13-propanoic acid derivatives, their preparation and therapeutic use |
07/03/1996 | EP0719277A1 Androstenones |
07/03/1996 | EP0719146A1 Novel method of progesterone delivery and affect thereof |
07/03/1996 | EP0719143A1 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
07/03/1996 | EP0719140A1 Use of thiazolidinediones to prevent or delay onset of niddm |
07/02/1996 | US5532925 Current-to-pressure transducer with selectable, adjustable input filter |
07/02/1996 | US5532400 2,6-di-alkyl-4-silyl-phenols as antiatheroscelerotic agents |
06/30/1996 | CA2166233A1 8-oxo-5,8-dihydro-6h-dibenzo¬a,g|quinolizine-13-propanoic acid derivatives, their preparation and their therapeutic application |
06/27/1996 | WO1996019458A2 Steroid receptor modulator compounds and methods |
06/27/1996 | WO1996019455A1 Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists |
06/27/1996 | WO1996019203A1 Transdermal system for the simultaneous delivery of a number of active principles |
06/27/1996 | CA2208374A1 Transdermal system for the simultaneous delivery of a number of active principles |
06/27/1996 | CA2208347A1 Steroid receptor modulator compounds and methods |
06/27/1996 | CA2208011A1 Aryl-and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists |
06/26/1996 | EP0718286A1 3-Alkoxybenzylpiperidine derivatives as melatonergic agents |
06/26/1996 | CN1125436A Vitamin D amide derivatives |
06/25/1996 | US5530012 3-alkoxybenzylpiperidine derivatives as melatonergic agents |
06/25/1996 | US5529993 Urogenital disorders; contraceptives |
06/23/1996 | CA2165603A1 3-alkoxybenzylpiperidine derivatives as melatonergic agents |
06/20/1996 | WO1996018651A1 Human somatostatin-like receptor |
06/19/1996 | CN1124978A Cell matrix stimulated cell attachment and hemidesmosome assembly |
06/18/1996 | US5527807 Treating alopecia, acne, prostate disorders |
06/12/1996 | EP0715518A1 Agent for transdermal application containing gestoden esters |
06/11/1996 | US5525613 Covalently coupled benzoylecgonine ecgonine and ecgonidine |
06/11/1996 | US5525594 Administering a plant extract oenotheine b to inhibit 5 alpha-reductase |
06/06/1996 | WO1996016542A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
06/04/1996 | US5523298 Used to induce labor, abortion, menstruation, and againsts hormonal irregularities |
05/30/1996 | WO1996015804A1 Acylated insulin analogs |
05/30/1996 | CA2205060A1 Acylated insulin analogs |
05/29/1996 | EP0713699A2 Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders |
05/29/1996 | EP0415924B1 Regulation of cell proliferation and differentiation using peptides |
05/23/1996 | WO1996015148A2 Low molecular weight peptidomimetic growth hormone secretagogues |
05/23/1996 | WO1996009831A3 Compositions containing at least one glucocorticoid in combination with a pulmonary surfactant for the treatment of irds and ards |
05/23/1996 | WO1996009826A3 Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy |
05/23/1996 | CA2203375A1 Low molecular weight peptidomimetic growth hormone secretagogues |
05/22/1996 | EP0712861A2 Acylated insulin analogs |
05/22/1996 | EP0712412A1 15,15-dialkyl-substituted derivatives of estradiol |
05/22/1996 | EP0712303A1 Skin patches and methods for providing testosterone |
05/21/1996 | US5519116 Peptides representing permutations of the mastoparan sequence |
05/21/1996 | US5519027 D-homo-(16-ene)-11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents |
05/17/1996 | WO1996014082A1 Methods and kits using macrophage stimulating protein |
05/15/1996 | EP0711287A1 Benzo-fused lactams promote release of growth hormone |
05/15/1996 | CN1122248A Insulin analog formulations |
05/15/1996 | CN1122226A Tablet, capsule, or granule comprising desogestrel |
05/14/1996 | US5516887 Luteinizing hormone releasing hormone antagonist peptides |
05/14/1996 | US5516769 Administering an antiprogestin to prevent ovulation or interfere with the menstrual cycle of a mammal |
05/09/1996 | WO1996013585A1 A novel family of protease inhibitors, and other biologic active substances |
05/09/1996 | WO1996013265A1 4-heterocyclic piperidines promote release of growth hormone |
05/09/1996 | CA2203827A1 Novel family of protease inhibitors, and other biologic active substances |
05/09/1996 | CA2202784A1 4-heterocyclic piperidines promote release of growth hormone |
05/08/1996 | EP0710278A1 Cell matrix stimulated cell attachment and hemidesmosome assembly |
05/08/1996 | EP0710230A1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists |
05/08/1996 | EP0517778B1 Vasoactive vasotocin derivatives |
05/08/1996 | CN1121821A Health Chinese medicine Massa Medicata fermentata oral liquid and its preparing method |
05/07/1996 | US5514673 Pharmaceutical composition containing lipophilic drugs |
05/01/1996 | EP0708656A1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines |
05/01/1996 | CN1121709A Oxytocin antagonist |
04/30/1996 | US5512583 Methods of decreasing serum calcium levels |
04/30/1996 | CA1338302C Therapeutic octapeptide somatostatin analogs |
04/30/1996 | CA1338301C Therapeutic octapeptide somatostatin analogs |
04/25/1996 | WO1996012034A1 A microbiological process for the preparation of 17beta-carboxy substituted 3-oxo-4-azasteroids and the use of such products as inhibitors of the enzyme 5alpha-reductase |
04/24/1996 | EP0707596A1 Conjugation-stabilized polypeptide compositions |
04/23/1996 | US5510498 Benzothiophene compounds, intermediates, compositions, and methods |
04/23/1996 | US5510464 Administration of low dose hemoglobin to increase perfusion |
04/23/1996 | US5510358 Osteoporosis |
04/23/1996 | US5510357 Benzothiophene compounds as anti-estrogenic agents |
04/23/1996 | US5510350 Useful in treatment or prophylaxis of depression and other central nervous system disorders |
04/23/1996 | US5510263 Growth of pancreatic islet-like cell clusters |
04/17/1996 | EP0706994A1 Melatonergic agents |
04/17/1996 | CN1120843A 1,5-benzodiazepine derivatives having CCK antagonistic or agonistic activity |
04/17/1996 | CN1120549A Calcitonin analogue and use thereof |
04/17/1996 | CN1120458A Physiologically active peptide compositions |
04/17/1996 | CN1120457A Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same |
04/17/1996 | CN1031574C Process for preparation of 4-amino-delta-4, 6-steroid(s) compounds |
04/11/1996 | WO1996010634A1 Inhibitor of stem cell proliferation and uses thereof |
04/10/1996 | CN1120311A Pharmaceutical composition containing lipophilic drugs |
04/09/1996 | US5506339 Octapeptide analogs of somatostatin having threonine at the sixth position |
04/09/1996 | US5506107 Selecting ligand agonists and antagonists |
04/04/1996 | WO1996010088A1 DEFFECTIVE RECOMBINANT ADENOVIRUSES WITH INACTIVATED IVa2 GENE |
04/04/1996 | WO1996010040A1 Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone |
04/04/1996 | WO1996009831A2 Compositions containing at least one glucocorticoid in combination with a pulmonary surfactant for the treatment of irds and ards |
04/04/1996 | WO1996009826A2 Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy |
04/04/1996 | CA2201122A1 Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone |
04/04/1996 | CA2200858A1 Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy |
04/04/1996 | CA2197904A1 Deffective recombinant adenoviruses with inactivated iva2 gene |
04/03/1996 | EP0704448A1 Heterocyclic substituted imidazolidines, process and intermediates for their preparation, their use as medicaments and pharmaceutical compositions containing them |
04/02/1996 | US5504188 Crystallization of lys(b28)pro(b29)-human insulin zinc salt at a ph of about 5.5 to 6.5 from a solution also containing acetic acid, citric acid, glycine or phenolic compound |
03/30/1996 | CA2159425A1 New heterocycle substituted imidazolidines; process and intermediates for preparing them and their use as drugs; pharmaceutical compositions containing the same |
03/28/1996 | WO1996009046A1 5α-REDUCTASE INHIBITORS |
03/28/1996 | WO1996009045A1 Antiestrogenic benzothiophenyl compounds |
03/27/1996 | EP0703221A1 5 alpha-reductase Inhibitors |
03/21/1996 | DE19534744A1 Neues pharmazeutisches Produkt New pharmaceutical product |
03/20/1996 | EP0556332B1 Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents |
03/20/1996 | CN1118781A Heterocyclic compound with activity against diabetes and preparation and application of same |
03/14/1996 | WO1996007418A1 Phosphonates and parathyroid hormone for osteoporosis |
03/14/1996 | WO1996007417A1 Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone |
03/14/1996 | CA2199252A1 Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone |
03/14/1996 | CA2199251A1 Phosphonates and parathyroid hormone for osteoporosis |